Literature DB >> 23485794

The feasibility of a 3-month active rehabilitation program for patients with knee full-thickness articular cartilage lesions: the Oslo Cartilage Active Rehabilitation and Education Study.

Barbara Wondrasch1, Asbjørn Arøen, Jan Harald Røtterud, Turid Høysveen, Kristin Bølstad, May Arna Risberg.   

Abstract

STUDY
DESIGN: Case series.
OBJECTIVES: To evaluate the feasibility of an active rehabilitation program for patients with knee full-thickness articular cartilage lesions.
BACKGROUND: No studies have yet evaluated the effect of active rehabilitation in patients with knee full-thickness articular cartilage lesions or compared the effects of active rehabilitation to those of surgical interventions. As an initial step, the feasibility of such a program needs to be described.
METHODS: Forty-eight patients with a knee full-thickness articular cartilage lesion and a Lysholm score below 75 participated in a 3-month active rehabilitation program consisting of cardiovascular training, knee and hip progressive resistance training, and neuromuscular training. Feasibility was determined by monitoring adherence to the program, clinical changes in knee function, load progression, and adverse events. Patients were tested before and after completing the rehabilitation program by using patient-reported outcomes (Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee Subjective Knee Evaluation Form 2000) and isokinetic muscle strength and hop tests. To monitor adherence, load progression, and adverse events, patients responded to an online survey and kept training diaries.
RESULTS: The average adherence rate to the rehabilitation program was 83%. Four patients (9%) showed adverse events, as they could not perform the exercises due to pain and effusion. Significant and clinically meaningful improvement was found, based on changes on the International Knee Documentation Committee Subjective Knee Evaluation Form 2000, the Knee injury and Osteoarthritis Outcome Score quality of life subscale, isokinetic muscle strength, and hop performance (P<.05), with small to large effect sizes (standardized response mean, 0.3-1.22).
CONCLUSION: The combination of a high adherence rate, clinically meaningful changes, and positive load progression and the occurrence of only a few adverse events support the potential usefulness of this program for patients with knee full-thickness cartilage lesions. This study was registered with the public trial registry ClinicalTrials.gov (NCT00885729). LEVEL OF EVIDENCE: Therapy, level 4.

Entities:  

Mesh:

Year:  2013        PMID: 23485794     DOI: 10.2519/jospt.2013.4354

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  10 in total

Review 1.  Concise review: unraveling stem cell cocultures in regenerative medicine: which cell interactions steer cartilage regeneration and how?

Authors:  Tommy S de Windt; Jeanine A A Hendriks; Xing Zhao; Lucienne A Vonk; Laura B Creemers; Wouter J A Dhert; Mark A Randolph; Daniel B F Saris
Journal:  Stem Cells Transl Med       Date:  2014-04-24       Impact factor: 6.940

2.  The Effect of Lesion Size on Pain and Function in Patients Scheduled for Cartilage Surgery of the Knee.

Authors:  Per-Henrik Randsborg; Asbjørn Årøen; Christian Owesen
Journal:  Cartilage       Date:  2022 Apr-Jun       Impact factor: 3.117

3.  Evaluation of focal cartilage lesions of the knee using MRI T2 mapping and delayed Gadolinium Enhanced MRI of Cartilage (dGEMRIC).

Authors:  Asbjørn Årøen; Helga Brøgger; Jan Harald Røtterud; Einar Andreas Sivertsen; Lars Engebretsen; May Arna Risberg
Journal:  BMC Musculoskelet Disord       Date:  2016-02-11       Impact factor: 2.362

4.  Quantifying Quadriceps Muscle Strength in Patients With ACL Injury, Focal Cartilage Lesions, and Degenerative Meniscus Tears: Differences and Clinical Implications.

Authors:  Ingrid Eitzen; Hege Grindem; Agnethe Nilstad; Håvard Moksnes; May Arna Risberg
Journal:  Orthop J Sports Med       Date:  2016-10-11

5.  No degeneration found in focal cartilage defects evaluated with dGEMRIC at 12-year follow-up.

Authors:  Cathrine Nørstad Engen; Sverre Løken; Asbjørn Årøen; Charles Ho; Lars Engebretsen
Journal:  Acta Orthop       Date:  2016-11-24       Impact factor: 3.717

Review 6.  Microfracture is more cost-effective than autologous chondrocyte implantation: a review of level 1 and level 2 studies with 5 year follow-up.

Authors:  Tommy Frøseth Aae; Per-Henrik Randsborg; Hilde Lurås; Asbjørn Årøen; Øystein Bjerkestrand Lian
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-11       Impact factor: 4.342

7.  Relationship between CTX-II and patient characteristics, patient-reported outcome, muscle strength, and rehabilitation in patients with a focal cartilage lesion of the knee: a prospective exploratory cohort study of 48 patients.

Authors:  Jan Harald Røtterud; Finn P Reinholt; Karen Johanne Beckstrøm; May Arna Risberg; Asbjørn Arøen
Journal:  BMC Musculoskelet Disord       Date:  2014-03-24       Impact factor: 2.362

8.  Norwegican Cartilage Project - a study protocol for a double-blinded randomized controlled trial comparing arthroscopic microfracture with arthroscopic debridement in focal cartilage defects in the knee.

Authors:  Tommy Frøseth Aae; Per-Henrik Randsborg; Anne Berg Breen; Håvard Visnes; Søren Vindfeld; Einar Andreas Sivertsen; Sverre Løken; Jan Brinchmann; Heidi Andreassen Hanvold; Asbjørn Årøen
Journal:  BMC Musculoskelet Disord       Date:  2016-07-16       Impact factor: 2.362

9.  Focal cartilage defects in the knee - a randomized controlled trial comparing autologous chondrocyte implantation with arthroscopic debridement.

Authors:  Per-Henrik Randsborg; Jan Brinchmann; Sverre Løken; Heidi Andreassen Hanvold; Tommy Frøseth Aae; Asbjørn Årøen
Journal:  BMC Musculoskelet Disord       Date:  2016-03-08       Impact factor: 2.362

10.  Better before-better after: efficacy of prehabilitation for older patients with osteoarthritis awaiting total hip replacement-a study protocol for a randomised controlled trial in South-Eastern Norway.

Authors:  Odd-Einar Svinøy; Astrid Bergland; May Arna Risberg; Are Hugo Pripp; Gunvor Hilde
Journal:  BMJ Open       Date:  2019-12-30       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.